SCHEMBL25869402

SCHEMBL25869402

CCCCOCCCCC(CO)CO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
TSHR P16473 2/20 0.54
ALDH1A1 P00352 1/20 0.52
HTT P42858 2/20 0.48
MEN1 O00255 1/20 0.48
THRB P10828 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPT P10636 1/20 0.48
USP2 O75604 1/20 0.47
CYP3A4 P08684 2/20 0.40
GBA2 Q9HCG7 2/20 0.38
GBA1 P04062 1/20 0.38
CES2 O00748 1/20 0.36
PLA2G2C Q5R387 1/20 0.36
SPHK1 Q9NYA1 1/20 0.35
GMNN O75496 1/20 0.35
POLB P06746 1/20 0.35
CYP2D6 P10635 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octyldodecanol SCHEMBL5684802 0.89 LMNA (0.75) LMNATSHRALDH1A1HTTMEN1
SCHEMBL8351729 0.89 TSHR (0.56) LMNATSHRALDH1A1HTTMEN1
SCHEMBL1072086 0.88 MEN1 (0.55) LMNATSHRALDH1A1HTTMEN1
SCHEMBL20854596 0.86 MEN1 (0.59) LMNATSHRALDH1A1HTTMEN1
SCHEMBL27929287 0.85 ALDH1A1 (0.75) LMNATSHRALDH1A1HTTMEN1
Octane SCHEMBL11341855 0.82 ALDH1A1 (0.69) LMNATSHRALDH1A1HTTMEN1
SCHEMBL22426 0.81 LMNA (0.84) LMNATSHRALDH1A1HTTMEN1
SCHEMBL13986871 0.81 TSHR (0.52) LMNATSHRALDH1A1HTTMEN1
SCHEMBL1022652 0.81 USP2 (0.60) LMNATSHRHTTMEN1THRB
SCHEMBL15508256 0.81 USP2 (0.60) LMNATSHRHTTMEN1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238212-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS Suzhou Abogen Biosciences Co., Ltd. (CN) 2024-07-18 US disclosed
US-20230233468-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230233468-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS CETP, NPC1, LCAT LMNA 305/4885TSHR 4616/4885ALDH1A1 4264/4885
US-20240238212-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS CETP, NPC1, LCAT LMNA 305/4885TSHR 4616/4885ALDH1A1 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.